Healthequity (NASDAQ:HQY) updated its FY18 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $0.64 -0.66 for the period, compared to the Thomson Reuters consensus estimate of $0.66. The company issued revenue guidance of $225.0 -228.0 million, compared to the consensus revenue estimate of $227.47 million.
Healthequity (NASDAQ HQY) traded up $1.33 during mid-day trading on Thursday, reaching $54.69. The company had a trading volume of 830,300 shares, compared to its average volume of 503,389. Healthequity has a 12-month low of $37.62 and a 12-month high of $55.31. The firm has a market cap of $3,237.49, a PE ratio of 73.91, a price-to-earnings-growth ratio of 2.04 and a beta of 1.70.
Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.13 by $0.04. The firm had revenue of $56.80 million during the quarter, compared to analysts’ expectations of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The business’s revenue was up 31.0% on a year-over-year basis. During the same period last year, the firm posted $0.10 EPS. equities analysts expect that Healthequity will post 0.73 earnings per share for the current year.
In related news, insider Jon Kessler sold 40,000 shares of Healthequity stock in a transaction dated Thursday, January 25th. The stock was sold at an average price of $49.47, for a total value of $1,978,800.00. Following the sale, the insider now owns 485,000 shares of the company’s stock, valued at $23,992,950. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Ashley Dreier sold 10,000 shares of Healthequity stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $50.97, for a total value of $509,700.00. Following the completion of the sale, the vice president now directly owns 15,652 shares in the company, valued at approximately $797,782.44. The disclosure for this sale can be found here. Insiders sold a total of 797,247 shares of company stock worth $40,881,661 in the last three months. Company insiders own 29.00% of the company’s stock.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.